Clinical trial
Characterization of Immune Responses in Treatment-induced Latency in Pulmonary Tuberculosis
NCT01154959 is registered in ClinicalTrials.gov with Tuberculosis Research Centre, India as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characterization of Immune Responses in Treatment-induced Latency in Pulmonary Tuberculosis
- Lead sponsor
- Tuberculosis Research Centre, India
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 28, 2010
- Completion date
- July 31, 2016
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pulmonary tuberculosis